» Articles » PMID: 36750862

Development and Validation of a Nomogram to Predict Failure of 14-day Negative Nucleic Acid Conversion in Adults with Non-severe COVID-19 During the Omicron Surge: a Retrospective Multicenter Study

Overview
Publisher Biomed Central
Date 2023 Feb 8
PMID 36750862
Authors
Affiliations
Soon will be listed here.
Abstract

Background: With the variability in emerging data, guidance on the isolation duration for patients with coronavirus disease 2019 (COVID-19) due to the Omicron variant is controversial. This study aimed to determine the predictors of prolonged viral RNA shedding in patients with non-severe COVID-19 and construct a nomogram to predict patients at risk of 14-day PCR conversion failure.

Methods: Adult patients with non-severe COVID-19 were enrolled from three hospitals of eastern China in Spring 2022. Viral shedding time (VST) was defined as either the day of the first positive test or the day of symptom onset, whichever was earlier, to the date of the first of two consecutively negative PCR tests. Patients from one hospital (Cohort I, n = 2033) were randomly grouped into training and internal validation sets. Predictors of 14-day PCR conversion failure were identified and a nomogram was developed by multivariable logistic regression using the training dataset. Two hospitals (Cohort II, n = 1596) were used as an external validation set to measure the performance of this nomogram.

Results: Of the 2033 patients from Cohort I, the median VST was 13.0 (interquartile range: 10.0‒16.0) days; 716 (35.2%) lasted > 14 days. In the training set, increased age [per 10 years, odds ratio (OR) = 1.29, 95% confidence interval (CI): 1.15‒1.45, P < 0.001] and high Charlson comorbidity index (OR = 1.25, 95% CI: 1.08‒1.46, P = 0.004) were independent risk factors for VST > 14 days, whereas full or boosted vaccination (OR = 0.63, 95% CI: 0.42‒0.95, P = 0.028) and antiviral therapy (OR = 0.56, 95% CI: 0.31‒0.96, P = 0.040) were protective factors. These predictors were used to develop a nomogram to predict VST > 14 days, with an area under the ROC curve (AUC) of 0.73 in the training set (AUC, 0.74 in internal validation set; 0.76 in external validation set).

Conclusions: Older age, increasing comorbidities, incomplete vaccinations, and lack of antiviral therapy are risk factors for persistent infection with Omicron variant for > 14 days. A nomogram based on these predictors could be used as a prediction tool to guide treatment and isolation strategies.

Citing Articles

Estimating the association between cigarette and e-cigarette use patterns and SARS-CoV-2 negative conversion time: retrospective online survey in China.

Xie Y, Li Y, Su Z, Han X, Liu Z, Huang Z BMC Infect Dis. 2025; 25(1):161.

PMID: 39901130 PMC: 11792595. DOI: 10.1186/s12879-025-10545-x.


Efficacy of traditional Chinese medicine on shortening the negative conversion time of SARS-CoV-2 ribonucleic acid in patients with mild COVID-19: a retrospective cohort study.

Chen Y, Yang M, Tian Y, Chen X, Lu W, Wei H Sci One Health. 2024; 2:100049.

PMID: 39077047 PMC: 11262282. DOI: 10.1016/j.soh.2023.100049.


Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.

Wang Y, Yu H, Zhang T, Sun Z, Yao W, Zhang W Virus Res. 2024; 345:199400.

PMID: 38763300 PMC: 11137596. DOI: 10.1016/j.virusres.2024.199400.


Study on the correlation between lifestyle and negative conversion time in patients diagnosed with coronavirus disease (COVID-19): a retrospective cohort study.

Li N, Liu C, Qiu L, Shen C, Zhang F, Lu Z BMC Public Health. 2023; 23(1):2410.

PMID: 38049851 PMC: 10696701. DOI: 10.1186/s12889-023-17163-9.


Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort.

Grimaldi P, Russo A, Pisaturo M, Maggi P, Allegorico E, Gentile I Infection. 2023; 52(2):439-446.

PMID: 37704910 PMC: 10954924. DOI: 10.1007/s15010-023-02095-8.

References
1.
Shen Y, Ai J, Lin N, Zhang H, Li Y, Wang H . An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants. Emerg Microbes Infect. 2022; 11(1):1518-1523. PMC: 9176639. DOI: 10.1080/22221751.2022.2078230. View

2.
Rhee C, Kanjilal S, Baker M, Klompas M . Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?. Clin Infect Dis. 2020; 72(8):1467-1474. PMC: 7499497. DOI: 10.1093/cid/ciaa1249. View

3.
Cheung P, Chan C, Jin D . Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect. 2022; 11(1):1072-1078. PMC: 9004509. DOI: 10.1080/22221751.2022.2060137. View

4.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T . COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022; 7(1):146. PMC: 9062866. DOI: 10.1038/s41392-022-00996-y. View

5.
Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M . Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022; 399(10323):437-446. PMC: 8769664. DOI: 10.1016/S0140-6736(22)00017-4. View